Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014819 · ClinicalTrials.gov registry record
A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions
A clinical trial, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- 30
- Enrollment target
NCT01014819: Completed study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT01014819 is a clinical trial that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01014819 has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The Dermacorder measures the electric field in the skin. Malignant skin lesions disrupt the skin's normal electric field and this abnormal electric field can be detected by the Dermacorder. Therefore the investigators are testing the hypothesis that the Dermacorder can provide useful data to guide in the diagnosis of skin disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-07 |
What the finished NCT01014819 record still lists
NCT01014819 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01014819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01014819 about?
NCT01014819 is a clinical study titled "A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions". The Dermacorder measures the electric field in the skin. Malignant skin lesions disrupt the skin's normal electric field and this abnormal electric field can be detected by the Dermacorder. Therefore the investigators are testing the hypothesis that the Dermacorder can provide useful data to guide i...
What is the current status of trial NCT01014819?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2009-10. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT01014819?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia